FTC staff recommends approval of Roche deal for Spark: report [Reuters]
SPARK THERAPEUTICS INC (ONCE)
Last spark therapeutics inc earnings: 11/7 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.sparktx.com/investor-overview
Company Research
Source: Reuters
FTC staff recommends approval of Roche deal for Spark: report - Reuters 2 Min Read WASHINGTON (Reuters) - The Federal Trade Commission staff reviewing Roche’s ( RBO.PA ) plan to buy U.S.-based gene therapy specialist Spark Therapeutics ( ONCE.O ) for $4.3 billion recommended that the deal be approved without requiring any asset sales, the Capitol Forum reported on Thursday. Basel-based Roche, the biggest maker of cancer drugs, said in February that it would buy the U.S. company, acquiring a portfolio that includes a blindness treatment that has U.S. and European approval and other projects for neurodegenerative disorders like Huntington’s disease. One of its projects is a gene therapy treatment for hemophilia. The FTC staff had focused on hemophilia treatments since Roche markets Hemlibra, the report said. Following the staff’s recommendation, officials at the top of the FTC’s Bureau of Competition must weigh in. The next step would be a vote by the FTC chairman and four commissio
Show less
Read more
Impact Snapshot
Event Time:
ONCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCE alerts
High impacting SPARK THERAPEUTICS INC news events
Weekly update
A roundup of the hottest topics